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More Lean, Less Fat With Clenbuterol
Joan H. Eisemann, Gerald B. Huntington, and Calvin L. Ferrell"2
Introduction
There is too much fat on beef carcasses today.
Research in beef cattle production is directed towards
solving this problem by maximizing partitioning of dietary
nutrients to lean muscle growth and minimizing deposition of carcass fat. Partitioning agents called 8 adrenergic agonists are able to cause this type of nutrient
partitioning. Earlier work showed two of these compounds, clenbuterol and cimaterol, can be fed and are
effective in many species including pigs, sheep, and cattle. At levels that did not depress gain, clenbuterol
feeding increased protein content of the 9th to 11th rib
section by 13% and decreased fat content by 20% in cattle. Even more dramatic carcass changes were observed in cattle in response to cimaterol.
Of interest are the underlying metabolic changes and
controls that must be altered to bring about the carcass
changes previously cited. To date, the mechanisms
responsible for altering nutrient partitioning in response
to

B -adrenergic

agonists

are not well defined.

The ob-

jectives of our study were to compare the initial and
adapted effects of clenbuterol on blood flow, heart rate,
and metabolism in the hindquarters of growing steers.

Procedure
Animals and diets.

The experimental

design

was a balanced,

single reversal including a 9-day control period and a
9-day period of clenbuterol feeding (8 mglday divided
equally across feedings) with a 5-day interim period.
Meals with clenbuterol were prepared daily for each steer
to assure daily allotment of 8 mg per steer. Meals fed during sampling were prepared separately to assure each
meal contained 2 mg clenbuterol.
Blood samples were collected on days 1 and 9 of each
period. Blood was withdrawn simultaneously from the abdominal aorta (A) and caudal vena cava (V) at 30-min intervals beginning at 7 a.m. for one feeding cycle (6 hr,
13 samples per steer). Blood samples were collected in

'Eisemann is a research physiologist,
Nutrition Unit,
MARC; Huntington is a research animal scientist, Beltsville
Agricultural Research Center, Maryland; and Ferrell is a research
animal scientist, Nutrition Unit, MARC.
'The full report of this work was published in J. Anim. Sci.
66:342-353, 1988.
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Plasma flow (Umin) = (1 -(PCV/100))· Blood flow (Umin)
Net uptake or release of nutrients was calculated as
the product of arteriovenous (AV) concentration difference and whole blood (or plasma) flow.
Results
Initial consumption of clenbuterol caused a rapid
doubling of heart rate (Fig. 1a). Heart rate decreased
slightly from this peak but remained elevated and relatively constant throughout the duration of sampling on day
1. There was some fluctuation in heart rate after control
feeding but no dramatic changes. Blood flow showed a

Four Hereford steers, 11 mo of age,

were gentled and adapted to a diet formulated to meet
protein requirements for 2.21b daily wt gain at restricted
intake beginning 1 mo before surgery. Catheters were
surgically implanted with tips in the aorta and caudal vena
cava in order to sample blood supplying and draining the
hindquarters. Also, an ultrasonic flow probe was placed
around the abdominal aorta for measurement of blood
flow to the hindquarters.
Following surgery, the steers were moved to individual
stalls in a completely enclosed room having a lightdark
cycle (hr) of 16L:8D. The diet was fed to steers in 4 equal
aliquots at 6 hr intervals beginning at 7 a.m. Steers consumed all their feed prior to and on each sampling day.
The experiment began 2 wk after surgery. Average body
wt was 531 lb.

Design.

heparinized syringes and immediately placed on ice. Aliquots of whole blood were removed for later analyses;
packed cell volume (PCV) was determined; and the
samples were centrifuged at 1500 x g for 20 min at 39°F
to obtain plasma. Plasma was aliquoted and stored at 4°F
until analysis. A transit time ultrasonic blood flow meter
was used to measure blood flow and heart rate at the time
of each blood sample.
Calculations. Plasma flow was calculated using the
following equation:
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Figure 1-Heart rate and blood flow to the hindquarters in steers
at each sampling time. Sampling began at 7 a.m. and continued for 6 hr at 30 min intervals. The arrow indicates time
of feeding. A: Samples taken on day 1 of control (
) or
clenbuterol (o~) treatment. Average SEM for control and
clenbuterol treatments, respectively, was: heart rate (beats
per min),3.2 and 4.4; blood flow (liters per min), 1.00and 1.12.
B: Samples taken on day 9 of control (
) or clenbuterol
(0--0)treatment. Average SEM of control and clenbuterol treatment, respectively, was: heart rate (beats per min), 5 and 4;
blood flow (liters per min), .82 and 1.02.

response similar to that of heart rate. By day 9, heart rate
and blood flow did not increase following consumption
of clenbuterol at the beginning of the sampling period;
however, on average, both heart rate and blood flow were
elevated (P < .01) after 9 days of clenbuterol compared
to control feeding (Fig. 1b).
The rapidity of the cardiovascular responses to initial
clenbuterol feeding (Fig. 1a) probably indicates the drug
is absorbed
in the proximal
sections
of the
gastrointestinal tract. Other researchers reported increased heart rate in young bull calves fed clenbuterol;
however, adaptation, indicated by a heart rate returned
to pretreatment values, occurred by day 3 of treatment.
Immediate increased heart rate in response to clenbuterol
or cimaterol was observed in sheep. An initial increase
in blood flow to the hindquarters in response to cimaterol
was observed also in sheep by other scientists.
On day 1, net uptake of oxygen increased and net uptake of a -amino nitrogen (AAN) decreased; whereas, net
release of both L-Iactate and free fatty acids (FFA) increased with clenbuterol compared to control feeding.
Oxygen is an indicator of total tissue metabolic activity;
AAN is a precursor of protein; L-Iactate is an end product
of muscle metabolism; and FFA are a precursor of tissue
fat and a source of energy. By day 9, clenbuterol feeding
caused a sustained increase in uptake of oxygen, increased uptake of AAN and increased net release of Llactate compared to control feeding. Net uptake of other
metabolites was not altered (P >.10) by initial (day 1) or
sustained (day 9) feeding of clenbuterol (Table 1).
By day 9 of treatment, hindquarters uptake of AAN was
increased, suggesting an increase in protein deposition
in response to chronic clenbuterol treatment. Previous
workers showed that sustained administration of clenbuterol to rats resulted in either an increase or no change
in fractional synthesis rate of muscle protein. Also, other

Table 1-Hindquarters

studies reported the fractional synthesis rate of muscle
protein was not altered in sheep with sustained clenbuterol administration. Therefore, the mechanism responsible for increased protein deposition is still not clear.
Comparing the immediate and sustained metabolic
responses to clenbuterol feeding exemplifies two types
of metabolic control, homeostasis (short-term regulation
to maintain similar conditions) and homeorhesis (Iongterm coordination of metabolism to support a dominant
physiological process, such as growth). Initially, the
steers showed a general catabolic response to a Badrenergic agonist by releasing stored nutrients and
decreasing peripheral anabolic processes (Table 2). The
rapid change in heart rate and blood flow after initial
feeding demonstrates the extent to which steady state
was altered and the need for rapid interplay of
homeostatic compensatory mechanisms. Adaptation is
indicated by lack of immediate response in blood flow
and heart rate to clenbuterol ingestion by day 9, and indicates the steers had reached a new steady state or were
moving along a more tightly regulated continuum.
Decreased AAN uptake by the hindquarters on day 1 and
increased AAN uptake on day 9 illustrate changing
metabolic control and the importance of chronic,
homeorhetic regulation.
Our data detail metabolic changes that contribute to
altered nutrient partitioning (increased muscle and
decreased fat accretion) previously observed in response
to clenbuterol feeding. Initial and sustained changes illustrate homeostatic
and homeorhetic
regulatory
mechanisms, respectively, for metabolic control. Perhaps
the data on AAN metabolism best illustrate the critical
need for longer-term evaluation of regulatory agents in
order to understand regulatory mechanisms coordinating
nutrient partitioning during growth.

uptake or release of nutrients in steers fed control and clenbuterol treatments
Day 1 (initial)

Uptake or release, mmoles/minb
Whole blood
Oxygen
Acetate
Propionate
D- B-hydroxybutyrate
Plasma
Glucose
L-Iactate
FFA ('}.Ieq/min)
AAN

Control

Clenbuterol

P<a

12.10
2.01
.103
.57

15.71
1.67
.109
.65

.06
NS
NS
NS

13.41
2.03
.140
.59

NS
.01
.07
.02

.89
.20
12
.34

.77
-.02
-111
.32

"'ype I error probability: NS = P > .10.
.Uptake or release = Blood or plasma flow x AV concentration

2.88
-1.59
-834
.10

Control

Day 9 (sustained)
Clenbuterol

P<a

16.47
1.41
.107
.80

.06
NS
NS
NS

1.03
-.46
-240
.49

NS
.07
NS
.02

difference.
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